Astrana Health (ASTH) FY2020 results: revenue $687 million, up 22.6% on the year
Astrana Health, Inc. (ASTH) reported revenue of $687 million for fiscal 2020, the year ended 31 December 2020, up 22.6% on the year before. Net income was $38 million, up 167.0%, and diluted earnings per share $1.01. The figures are the company's own, from the 10-K it filed with the SEC on 15 March 2021.
Revenue
$687 million
+22.6% on the year
FY2016FY2020
Operating margin
11.7%
5.8% a year earlier
FY2016FY2020
Net income
$38 million
+167.0% on the year
FY2016FY2020
Diluted EPS
$1.01
+159.0% on the year
FY2016FY2020
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Revenue
687
561
520
+22.6%
Cost of revenue
539
468
361
+15.3%
Gross profit
148
92.8
159
+59.4%
Gross margin
21.5%
16.6%
30.5%
Operating income
80.5
32.4
88.4
+148.3%
Operating margin
11.7%
5.8%
17.0%
Interest expense
9.5
4.7
0.6
+100.7%
Pre-tax income
178
25.8
82.6
+590.5%
Income tax
56.3
8.2
22.4
+589.9%
Effective tax rate
31.6%
31.6%
27.1%
Net income
37.7
14.1
10.8
+167.0%
Net margin
5.5%
2.5%
2.1%
Diluted EPS
$1.01
$0.39
$0.29
+159.0%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Operating cash flow
46.2
13.7
25.5
+237.6%
Capital expenditure
1.2
1.0
1.2
+11.7%
Free cash flow
45.0
12.6
24.3
+256.2%
Free cash flow margin
6.5%
2.3%
4.7%
Cash from investing
95.5
-181
-25.2
Cash from financing
-51.7
163
-11.2
Depreciation and amortisation
18.4
18.3
19.3
+0.4%
Share-based compensation
3.4
1.5
1.4
+118.7%
Buybacks
0.5
7.6
5.0
-92.9%
Dividends paid
51.3
61.7
17.8
-16.8%
Diluted shares, weighted
37m
36m
38m
+2.9%
Shares outstanding at period end
42m
36m
35m
+17.7%
Balance sheet
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Shareholders' equity
331
192
181
+72.7%
Non-controlling interest
0.1
0.8
1.0
-88.9%
Redeemable equity
114
169
225
-32.7%
Debt
241
242
0.0
-0.2%
Operating lease liabilities
15.9
11.4
0.0
+39.5%
Finance lease liabilities
0.3
0.4
0.5
-25.2%
Other liabilities
116
114
106
+1.3%
Total liabilities and equity
817
729
513
+12.2%
Fixed assets
n/a
n/a
12.7
Goodwill
232
239
186
-2.5%
Intangible assets
87.0
103
86.9
-15.6%
Investments
67.7
117
1.1
-41.9%
Cash and equivalents
193
103
107
+87.5%
Receivables
7.1
11.0
7.7
-35.9%
Other assets
230
156
112
+46.9%
Total assets
817
729
513
+12.2%
10-K for the year ended 31 December 2020, filed 15 March 2021: the filing.